Gold Nanoparticles: Recent Advances in the Biomedical Applications

Cell Biochemistry and Biophysics

Volumn 72, Issue 3, 2015, Pages 771-775

  Zhang, Xiaoying ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Drug carriers; Gold nanoparticles; Nanomaterials; Nanomedicine; Photodynamic therapy; Photothermal therapy

Indexed keywords

GOLD; METAL NANOPARTICLE;

ANIMAL; CHEMISTRY; GENE THERAPY; HUMAN; IMMUNOTHERAPY; NANOMEDICINE; NEOPLASMS; PHOTOCHEMOTHERAPY; PROCEDURES;

ANIMALS; GENETIC THERAPY; GOLD; HUMANS; IMMUNOTHERAPY; METAL NANOPARTICLES; NANOMEDICINE; NEOPLASMS; PHOTOCHEMOTHERAPY;

EID: 84933671341     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-015-0529-4     Document Type: Article

References (37)

1. Krpetic, Z., Anguissola, S., Garry, D., Kelly, P. M., & Dawson, K. A. (2014). Nanomaterials: Impact on cells and cell organelles. Advances in Experimental Medicine and Biology,811, 135–156.
2. Vigderman, L., & Zubarev, E. R. (2013). Therapeutic platforms based on gold nanoparticles and their covalent conjugates with drug molecules. Advanced Drug Delivery Reviews,65, 663–676.
3. Sanhai, W. R., Sakamoto, J. H., Canady, R., & Ferrari, M. (2008). Seven challenges for nanomedicine. Nature Nanotechnology,3, 242–244.
4. Valentini, P., & Pompa, P. P. (2013). Gold nanoparticles for naked-eye DNA detection: Smart designs for sensitive assays. RSC Advances,3, 19181–19190.
5. Ghosh, P., Han, G., De, M., Kim, C. K., & Rotello, V. M. (2008). Gold nanoparticles in delivery applications. Advanced Drug Delivery Reviews,60, 1307–1315.
6. Butterworth, K. T., McMahon, S. J., Currell, F. J., & Prise, K. M. (2012). Physical basis and biological mechanisms of gold nanoparticle radiosensitization. Nanoscale.,4, 4830–4838.
7. Lynch, I., Salvati, A., & Dawson, K. A. (2009). Protein-nanoparticle interactions: What does the cell see? Nature Nanotechnology,4, 546–547.
8. Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010). Endocytosis of nanomedicines. Journal of Control Release.,145, 182–195.
9. Gao, H., Shi, W., & Freund, L. B. (2005). Mechanics of receptor-mediated endocytosis. Proceedings of the National Academy of Sciences of the United States of America,102, 9469–9474.
10. Nel, A. E., Madler, L., Velegol, D., Xia, T., Hoek, E. M., Somasundaran, P., et al. (2009). Understanding biophysicochemical interactions at the nano-bio interface. Nature Materials,8, 543–557.
11. Lee, J., Chatterjee, D. K., Lee, M. H., & Krishnan, S. (2014). Gold nanoparticles in breast cancer treatment: Promise and potential pitfalls. Cancer Letters,347, 46–53.
12. Sau, T. K., & Murphy, C. J. (2004). Room temperature, high-yield synthesis of multiple shapes of gold nanoparticles in aqueous solution. Journal of the American Chemical Society,126, 8648–8649.
13. Lin, M., Pei, H., Yang, F., Fan, C., & Zuo, X. (2013). Applications of gold nanoparticles in the detection and identification of infectious diseases and biothreats. Advanced Materials,25, 3490–3496.
14. Bastus, N. G., Comenge, J., & Puntes, V. (2011). Kinetically controlled seeded growth synthesis of citrate-stabilized gold nanoparticles of up to 200 nm: Size focusing versus ostwald ripening. Langmuir,27, 11098–11105.
15. Grzelczak, M., Perez-Juste, J., Mulvaney, P., & Liz-Marzan, L. M. (2008). Shape control in gold nanoparticle synthesis. Chemical Society Reviews,37, 1783–1791.
16. Kanaras, A. G., Kamounah, F. S., Schaumburg, K., Kiely, C. J., Brust, M. (2002). Thioalkylated tetraethylene glycol: A new ligand for water soluble monolayer protected gold clusters. Chemical Communications (Camb), 20, 2294–2295.
17. Cao-Milan, R., & Liz-Marzan, L. M. (2014). Gold nanoparticle conjugates: Recent advances toward clinical applications. Expert Opinion on Drug Delivery,11, 741–752.
18. Khlebtsov, N., & Dykman, L. (2011). Biodistribution and toxicity of engineered gold nanoparticles: A review of in vitro and in vivo studies. Chemical Society Reviews,40, 1647–1671.
19. Popovtzer, R., Agrawal, A., Kotov, N. A., Popovtzer, A., Balter, J., Carey, T. E., & Kopelman, R. (2008). Targeted gold nanoparticles enable molecular ct imaging of cancer. Nano Letters,8, 4593–4596.
20. Hainfeld, J. F., Dilmanian, F. A., Slatkin, D. N., & Smilowitz, H. M. (2008). Radiotherapy enhancement with gold nanoparticles. Journal of Pharmacy and Pharmacology,60, 977–985.
21. Weissleder, R. (2001). A clearer vision for in vivo imaging. Nature Biotechnology,19, 316–317.
22. Dykman, L., & Khlebtsov, N. (2012). Gold nanoparticles in biomedical applications: Recent advances and perspectives. Chemical Society Reviews,41, 2256–2282.
23. Hainfeld, J. F., Smilowitz, H. M., O’Connor, M. J., Dilmanian, F. A., & Slatkin, D. N. (2013). Gold nanoparticle imaging and radiotherapy of brain tumors in mice. Nanomedicine (London).,8, 1601–1609.
24. Kah, J. C., Wong, K. Y., Neoh, K. G., Song, J. H., Fu, J. W., Mhaisalkar, S., et al. (2009). Critical parameters in the pegylation of gold nanoshells for biomedical applications: An in vitro macrophage study. Journal of Drug Targeting,17, 181–193.
25. Hainfeld, J. F., Slatkin, D. N., & Smilowitz, H. M. (2004). The use of gold nanoparticles to enhance radiotherapy in mice. Physics in Medicine & Biology,49, N309–315.
26. Dreaden, E. C., Mackey, M. A., Huang, X., Kang, B., & El-Sayed, M. A. (2011). Beating cancer in multiple ways using nanogold. Chemical Society Reviews,40, 3391–3404.
27. Dickerson, E. B., Dreaden, E. C., Huang, X., El-Sayed, I. H., Chu, H., Pushpanketh, S., et al. (2008). Gold nanorod assisted near-infrared plasmonic photothermal therapy (pptt) of squamous cell carcinoma in mice. Cancer Letters,269, 57–66.
28. Hainfeld, J. F., Dilmanian, F. A., Zhong, Z., Slatkin, D. N., Kalef-Ezra, J. A., & Smilowitz, H. M. (2010). Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma. Physics in Medicine & Biology,55, 3045–3059.
29. Giuliano, A. E., Hunt, K. K., Ballman, K. V., Beitsch, P. D., Whitworth, P. W., Blumencranz, P. W., et al. (2011). Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial. JAMA,305, 569–575.
30. Oberdorster, G., Oberdorster, E., & Oberdorster, J. (2005). Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environmental Health Perspectives,113, 823–839.
31. Lasagna-Reeves, C., Gonzalez-Romero, D., Barria, M. A., Olmedo, I., Clos, A., Sadagopa Ramanujam, V. M., et al. (2010). Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochemical and Biophysical Research Communications,393, 649–655.
32. Love, S. A., Thompson, J. W., & Haynes, C. L. (2012). Development of screening assays for nanoparticle toxicity assessment in human blood: Preliminary studies with charged au nanoparticles. Nanomedicine (London).,7, 1355–1364.
33. Glazer, E. S., Zhu, C., Hamir, A. N., Borne, A., Thompson, C. S., & Curley, S. A. (2011). Biodistribution and acute toxicity of naked gold nanoparticles in a rabbit hepatic tumor model. Nanotoxicology.,5, 459–468.
34. Gad, S. C., Sharp, K. L., Montgomery, C., Payne, J. D., & Goodrich, G. P. (2012). Evaluation of the toxicity of intravenous delivery of auroshell particles (gold-silica nanoshells). International Journal of Toxicology,31, 584–594.
35. Svarovsky, S. A., Szekely, Z., & Barchi, J. J. (2005). Synthesis of gold nanoparticles bearing the thomsen–friedenreich disaccharide: A new multivalent presentation of an important tumor antigen. Tetrahedron Asymmetry,16, 587–598.
36. Ojeda, R., de Paz, J. L., Barrientos, A. G., Martin-Lomas, M., & Penades, S. (2007). Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines. Carbohydrate Research,342, 448–459.
37. Parry, A. L., Clemson, N. A., Ellis, J., Bernhard, S. S., Davis, B. G., & Cameron, N. R. (2013). ‘Multicopy multivalent’ glycopolymer-stabilized gold nanoparticles as potential synthetic cancer vaccines. Journal of the American Chemical Society,135, 9362–9365.